ALVOGEN Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?
ALVOGEN has fifty-seven approved drugs.
There are two tentative approvals on ALVOGEN drugs.
Summary for ALVOGEN
US Patents: | 0 |
Tradenames: | 47 |
Ingredients: | 45 |
NDAs: | 57 |
Patent Litigation for ALVOGEN: | See patent lawsuits for ALVOGEN |
PTAB Cases with ALVOGEN as petitioner: | See PTAB cases with ALVOGEN as petitioner |
Drugs and US Patents for ALVOGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alvogen | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 205954-001 | Jan 24, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Alvogen | ACETYLCYSTEINE | acetylcysteine | SOLUTION;INHALATION, ORAL | 203853-001 | Jun 21, 2012 | AN | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALVOGEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-003 | Aug 1, 1984 | 4,066,755 | ⤷ Sign Up |
Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-002 | Aug 1, 1984 | 4,066,755 | ⤷ Sign Up |
Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-001 | Oct 31, 1985 | 3,900,481 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.